secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2022-07-14T23:59:59+00:00
Accession:  0001193125-22-193726
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics raises ~$200M in public offering, reports preliminary cash of $163.6M
--------------------------------------------------------------------------------

- Preliminary cash, cash equivalents and short-term investments of $163.6M as of June 30, 2022.
- Public offering of 10.8M shares at $18.50/share; gross proceeds ~$200M, up to $230M with overallotment.
- Underwriters granted 30-day option to purchase up to 1.6M additional shares at same price.
- Offering expected to close July 15, 2022.
- Underwriting agreement with J.P. Morgan and Cowen.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000119312522193726/0001193125-22-193726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000119312522193726/d326023d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-193726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer